Clinical Research Directory
Browse clinical research sites, groups, and studies.
Patient and Physician Preference Study in Resectable, Non-small Cell Lung Cancer Treatments
Sponsor: Bristol-Myers Squibb
Summary
The purpose of this study is to investigate the perspectives and preferences of patients and healthcare professionals (medical oncologists, pneumologists, thoracic surgeons) regarding treatment options in the resectable non-small cell lung cancer (NSCLC) setting
Official title: Patient and Physician Preferences for Potentially Resectable, Non-metastatic Non-small Cell Lung Cancer Treatments
Key Details
Gender
All
Age Range
18 Years - Any
Study Type
OBSERVATIONAL
Enrollment
55
Start Date
2024-11-25
Completion Date
2026-06-30
Last Updated
2025-12-04
Healthy Volunteers
No
Conditions
Interventions
Approved Non-small Cell Lung Cancer (NSCLC) therapies
As prescribed by treating physician
Locations (1)
Evidera
London, United Kingdom